{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:55:43Z","timestamp":1787003743803,"version":"build-2736575974"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["F31AI172625"],"award-info":[{"award-number":["F31AI172625"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI132111"],"award-info":[{"award-number":["R01AI132111"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-29002-5","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T08:56:13Z","timestamp":1764060973000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Enhancing antiretroviral delivery to secondary lymph nodes by targeting CD169\u2009+\u2009macrophages with HIV-mimicking nanoparticles"],"prefix":"10.1038","volume":"15","author":[{"given":"Josiane","family":"Fofana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Zahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn M.","family":"Reinhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suryaram","family":"Gummuluru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"29002_CR1","unstructured":"Global HIV & AIDS statistics\u2014Fact sheet | UNAIDS. https:\/\/www.unaids.org\/en\/resources\/fact-sheet."},{"key":"29002_CR2","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/nm.4411","volume":"23","author":"JD Estes","year":"2017","unstructured":"Estes, J. D. et al. Defining total-body AIDS-virus burden with implications for curative strategies. Nat. Med. 23, 1271\u20131276 (2017).","journal-title":"Nat. Med."},{"key":"29002_CR3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nrmicro.2015.5","volume":"14","author":"MJ Churchill","year":"2016","unstructured":"Churchill, M. J., Deeks, S. G., Margolis, D. M., Siliciano, R. F. & Swanstrom, R. HIV reservoirs: what, where and how to target them. Nat. Rev. Microbiol. 14, 55\u201360 (2016).","journal-title":"Nat. Rev. Microbiol."},{"key":"29002_CR4","doi-asserted-by":"publisher","first-page":"9838","DOI":"10.1073\/pnas.88.21.9838","volume":"88","author":"G Pantaleo","year":"1991","unstructured":"Pantaleo, G. et al. Lymphoid organs function as major reservoirs for human immunodeficiency virus. PNAS 88, 9838\u20139842 (1991).","journal-title":"PNAS"},{"key":"29002_CR5","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1126\/science.278.5341.1291","volume":"278","author":"JK Wong","year":"1997","unstructured":"Wong, J. K. et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278, 1291\u20131295 (1997).","journal-title":"Science"},{"key":"29002_CR6","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1038\/s41467-021-21724-0","volume":"12","author":"AM Cadena","year":"2021","unstructured":"Cadena, A. M. et al. Persistence of viral RNA in lymph nodes in ART-suppressed SIV\/SHIV-infected Rhesus Macaques. Nat. Commun. 12, 1474 (2021).","journal-title":"Nat. Commun."},{"key":"29002_CR7","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1126\/science.278.5341.1295","volume":"278","author":"D Finzi","year":"1997","unstructured":"Finzi, D. et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278, 1295\u20131300 (1997).","journal-title":"Science"},{"key":"29002_CR8","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.chom.2016.07.015","volume":"20","author":"AE Baxter","year":"2016","unstructured":"Baxter, A. E. et al. Single-Cell Characterization of Viral Translation-Competent Reservoirs in HIV-Infected Individuals. Cell Host. Microbe. 20, 368\u2013380 (2016).","journal-title":"Cell Host. Microbe."},{"key":"29002_CR9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nature16933","volume":"530","author":"R Lorenzo-Redondo","year":"2016","unstructured":"Lorenzo-Redondo, R. et al. Persistent HIV-1 replication maintains the tissue reservoir during therapy. Nature 530, 51\u201356 (2016).","journal-title":"Nature"},{"key":"29002_CR10","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1073\/pnas.1318249111","volume":"111","author":"CV Fletcher","year":"2014","unstructured":"Fletcher, C. V. et al. Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues. Proc. Natl. Acad. Sci. USA 111, 2307\u20132312 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"29002_CR11","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/COH.0b013e32835fc68a","volume":"8","author":"TJ Cory","year":"2013","unstructured":"Cory, T. J., Schacker, T. W., Stevenson, M. & Fletcher, C. V. Overcoming pharmacologic sanctuaries. Curr. Opin. HIV AIDS 8, 190\u2013195 (2013).","journal-title":"Curr. Opin. HIV AIDS"},{"key":"29002_CR12","doi-asserted-by":"publisher","first-page":"S272","DOI":"10.1086\/533415","volume":"197","author":"DR Bangsberg","year":"2008","unstructured":"Bangsberg, D. R. Preventing HIV antiretroviral resistance through better monitoring of treatment adherence. J. Infect. Dis. 197, S272\u2013S278 (2008).","journal-title":"J. Infect. Dis."},{"key":"29002_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s12160-016-9827-3","volume":"51","author":"Y Chen","year":"2017","unstructured":"Chen, Y., Chen, K. & Kalichman, S. C. Barriers to HIV medication adherence as a function of regimen simplification. Ann Behav Med 51, 67\u201378 (2017).","journal-title":"Ann Behav Med"},{"key":"29002_CR14","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.chom.2019.08.003","volume":"26","author":"M-AD Scheerder","year":"2019","unstructured":"Scheerder, M.-A.D. et al. HIV rebound is predominantly Fueled by genetically identical viral expansions from diverse reservoirs. Cell Host. Microbe. 26, 347-358.e7 (2019).","journal-title":"Cell Host. Microbe."},{"key":"29002_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005000","volume":"11","author":"M Pinkevych","year":"2015","unstructured":"Pinkevych, M. et al. HIV reactivation from latency after treatment interruption occurs on average every 5\u20138 days-implications for HIV remission. PLoS Pathog 11, e1005000 (2015).","journal-title":"PLoS Pathog"},{"key":"29002_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.106220","volume":"57","author":"C Flexner","year":"2021","unstructured":"Flexner, C., Owen, A., Siccardi, M. & Swindells, S. Long-acting drugs and formulations for the treatment and prevention of HIV infection. Int. J. Antimicrob. Agents 57, 106220 (2021).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"29002_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2021.105032","volume":"146","author":"OE Ariyo","year":"2022","unstructured":"Ariyo, O. E. & Jones, C. E. Use of long-acting injectable antiretroviral agents for human immunodeficiency virus: A review. J. Clin. Virol. 146, 105032 (2022).","journal-title":"J. Clin. Virol."},{"key":"29002_CR18","unstructured":"Research, C. for D. E. and. FDA Approves Cabenuva and Vocabria for the treatment of HIV-1 Infection. FDA (2021)."},{"key":"29002_CR19","unstructured":"Sunlenca\u00ae (lenacapavir) Receives FDA Approval as a First-in-Class, Twice-Yearly Treatment Option for People Living With Multi-Drug Resistant HIV. https:\/\/www.gilead.com\/news-and-press\/press-room\/press-releases\/2022\/12\/sunlenca-lenacapavir-receives-fda-approval-as-a-firstinclass-twiceyearly-treatment-option-for-people-living-with-multidrug-resistant-hiv."},{"key":"29002_CR20","unstructured":"WHO recommends the dapivirine vaginal ring as a new choice for HIV prevention for women at substantial risk of HIV infection. https:\/\/www.who.int\/news\/item\/26-01-2021-who-recommends-the-dapivirine-vaginal-ring-as-a-new-choice-for-hiv-prevention-for-women-at-substantial-risk-of-hiv-infection."},{"key":"29002_CR21","unstructured":"Commissioner, O. of the. FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention. FDA https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-injectable-treatment-hiv-pre-exposure-prevention (2021)."},{"key":"29002_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.115009","volume":"200","author":"M Ullah Nayan","year":"2023","unstructured":"Ullah Nayan, M. et al. Advances in long-acting slow effective release antiretroviral therapies for treatment and prevention of HIV infection. Adv. Drug Deliv. Rev. 200, 115009 (2023).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"29002_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski, C. A., Lombardo, F., Dominy, B. W. & Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug. Deliv. Rev. 46, 3\u201326 (2001).","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"29002_CR24","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1208\/s12248-009-9153-9","volume":"11","author":"S Weng Larsen","year":"2009","unstructured":"Weng Larsen, S. & Larsen, C. Critical factors influencing the in vivo performance of long-acting lipophilic solutions\u2014Impact on in vitro release method design. AAPS J 11, 762\u2013770 (2009).","journal-title":"AAPS J"},{"key":"29002_CR25","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/cpt.2186","volume":"109","author":"EMB Scholz","year":"2021","unstructured":"Scholz, E. M. B. & Kashuba, A. D. M. The lymph node reservoir: physiology, hiv infection, and antiretroviral therapy. Clin. Pharma Therapeutics 109, 918\u2013927 (2021).","journal-title":"Clin. Pharma Therapeutics"},{"key":"29002_CR26","doi-asserted-by":"publisher","first-page":"S641","DOI":"10.1093\/infdis\/jiu442","volume":"210","author":"S Gummuluru","year":"2014","unstructured":"Gummuluru, S., Ramirez, N.-G.P. & Akiyama, H. CD169-dependent cell-associated HIV-1 transmission: A driver of virus dissemination. J. Infect. Dis. 210, S641\u2013S647 (2014).","journal-title":"J. Infect. Dis."},{"key":"29002_CR27","doi-asserted-by":"publisher","first-page":"8813","DOI":"10.1128\/JVI.00992-14","volume":"88","author":"H Akiyama","year":"2014","unstructured":"Akiyama, H. et al. Virus particle release from glycosphingolipid-enriched microdomains is essential for dendritic cell-mediated capture and transfer of HIV-1 and henipavirus. J. Virol. 88, 8813\u20138825 (2014).","journal-title":"J. Virol."},{"key":"29002_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004146","volume":"10","author":"N Izquierdo-Useros","year":"2014","unstructured":"Izquierdo-Useros, N. et al. HIV-1 capture and transmission by dendritic cells: the role of viral glycolipids and the cellular receptor Siglec-1. PLoS Pathog. 10, e1004146 (2014).","journal-title":"PLoS Pathog."},{"key":"29002_CR29","doi-asserted-by":"publisher","first-page":"7475","DOI":"10.1073\/pnas.1201104109","volume":"109","author":"WB Puryear","year":"2012","unstructured":"Puryear, W. B., Yu, X., Ramirez, N. P., Reinhard, B. M. & Gummuluru, S. HIV-1 incorporation of host-cell-derived glycosphingolipid GM3 allows for capture by mature dendritic cells. Proc. Natl. Acad. Sci. USA 109, 7475\u20137480 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"29002_CR30","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1126\/science.aab2749","volume":"350","author":"X Sewald","year":"2015","unstructured":"Sewald, X. et al. Retroviruses use CD169-mediated trans-infection of permissive lymphocytes to establish infection. Science 350, 563\u2013567 (2015).","journal-title":"Science"},{"key":"29002_CR31","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.64179","volume":"10","author":"KA Haugh","year":"2021","unstructured":"Haugh, K. A. et al. In vivo imaging of retrovirus infection reveals a role for Siglec-1\/CD169 in multiple routes of transmission. Elife 10, e64179 (2021).","journal-title":"Elife"},{"key":"29002_CR32","doi-asserted-by":"publisher","unstructured":"Prenzler, S. et al. The role of sialic acid-binding immunoglobulin-like-lectin-1 (siglec-1) in immunology and infectious disease. Int Rev Immunol 1\u201326 (2021) https:\/\/doi.org\/10.1080\/08830185.2021.1931171.","DOI":"10.1080\/08830185.2021.1931171"},{"key":"29002_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006181","volume":"13","author":"JE Hammonds","year":"2017","unstructured":"Hammonds, J. E. et al. Siglec-1 initiates formation of the virus-containing compartment and enhances macrophage-to-T cell transmission of HIV-1. PLoS Pathog 13, e1006181 (2017).","journal-title":"PLoS Pathog"},{"key":"29002_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004751","volume":"11","author":"H Akiyama","year":"2015","unstructured":"Akiyama, H., Ramirez, N.-G.P., Gudheti, M. V. & Gummuluru, S. CD169-mediated trafficking of HIV to plasma membrane invaginations in dendritic cells attenuates efficacy of anti-gp120 broadly neutralizing antibodies. PLoS Pathog 11, e1004751 (2015).","journal-title":"PLoS Pathog"},{"key":"29002_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0069450","volume":"8","author":"R Gaudin","year":"2013","unstructured":"Gaudin, R. et al. Dynamics of HIV-containing compartments in macrophages reveal sequestration of virions and transient surface connections. PLoS ONE 8, e69450 (2013).","journal-title":"PLoS ONE"},{"key":"29002_CR36","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1128\/JVI.05915-11","volume":"86","author":"H Koppensteiner","year":"2012","unstructured":"Koppensteiner, H., Banning, C., Schneider, C., Hohenberg, H. & Schindler, M. Macrophage internal HIV-1 is protected from neutralizing antibodies. J. Virol. 86, 2826\u20132836 (2012).","journal-title":"J. Virol."},{"key":"29002_CR37","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1111\/j.1600-0854.2011.01281.x","volume":"12","author":"N Izquierdo-Useros","year":"2011","unstructured":"Izquierdo-Useros, N. et al. Dynamic imaging of cell-free and cell-associated viral capture in mature dendritic cells. Traffic 12, 1702\u20131713 (2011).","journal-title":"Traffic"},{"key":"29002_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000134","volume":"4","author":"HJ Yu","year":"2008","unstructured":"Yu, H. J., Reuter, M. A. & McDonald, D. HIV Traffics through a specialized, surface-accessible intracellular compartment during trans-infection of T cells by mature dendritic cells. PLoS Pathog. 4, e1000134 (2008).","journal-title":"PLoS Pathog."},{"key":"29002_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003291","volume":"9","author":"WB Puryear","year":"2013","unstructured":"Puryear, W. B. et al. Interferon-inducible mechanism of dendritic cell-mediated HIV-1 dissemination is dependent on Siglec-1\/CD169. PLoS Pathog. 9, e1003291 (2013).","journal-title":"PLoS Pathog."},{"key":"29002_CR40","doi-asserted-by":"crossref","unstructured":"Duncan, C. J. A. et al. High-Multiplicity HIV-1 infection and neutralizing antibody evasion mediated by the macrophage-T cell virological synapse. J. Virol. (2014).","DOI":"10.1128\/JVI.03245-13"},{"key":"29002_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005054","volume":"11","author":"DR Collins","year":"2015","unstructured":"Collins, D. R., Lubow, J., Lukic, Z., Mashiba, M. & Collins, K. L. VPR promotes macrophage-dependent HIV-1 infection of CD4+ T lymphocytes. PLoS Pathog 11, e1005054 (2015).","journal-title":"PLoS Pathog"},{"key":"29002_CR42","doi-asserted-by":"publisher","first-page":"E9041","DOI":"10.1073\/pnas.1804292115","volume":"115","author":"F Xu","year":"2018","unstructured":"Xu, F. et al. Membrane-wrapped nanoparticles probe divergent roles of GM3 and phosphatidylserine in lipid-mediated viral entry pathways. Proc. Natl. Acad. Sci. USA 115, E9041\u2013E9050 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"29002_CR43","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1021\/acsami.1c17415","volume":"14","author":"B Eshaghi","year":"2022","unstructured":"Eshaghi, B., Fofana, J., Nodder, S. B., Gummuluru, S. & Reinhard, B. M. Virus mimicking polymer nanoparticles targeting CD169+ macrophages as long-acting Nanocarriers for combination Antiretrovirals. ACS Appl. Mater. Interfaces 14, 2488\u20132500 (2022).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"29002_CR44","doi-asserted-by":"publisher","first-page":"2000649","DOI":"10.1002\/advs.202000649","volume":"7","author":"B Eshaghi","year":"2020","unstructured":"Eshaghi, B. et al. Stiffness of HIV-1 mimicking polymer nanoparticles modulates ganglioside-mediated cellular uptake and trafficking. Adv. Sci. (Weinh) 7, 2000649 (2020).","journal-title":"Adv. Sci. (Weinh)"},{"key":"29002_CR45","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.addr.2016.05.020","volume":"107","author":"BK Lee","year":"2016","unstructured":"Lee, B. K., Yun, Y. & Park, K. PLA micro- and nano-particles. Adv. Drug Deliv. Rev. 107, 176\u2013191 (2016).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"29002_CR46","doi-asserted-by":"publisher","first-page":"e185","DOI":"10.1016\/S2352-3018(20)30340-4","volume":"8","author":"C Orkin","year":"2021","unstructured":"Orkin, C. et al. Long-acting cabotegravir plus rilpivirine for treatment in adults with HIV-1 infection: 96-week results of the randomised, open-label, phase 3 FLAIR study. Lancet HIV 8, e185\u2013e196 (2021).","journal-title":"Lancet HIV"},{"key":"29002_CR47","first-page":"24","volume":"121","author":"DS Aschenbrenner","year":"2021","unstructured":"Aschenbrenner, D. S. First extended-release injectable drug therapy for HIV. Am. J. Nurs. 121, 24\u201325 (2021).","journal-title":"Am. J. Nurs."},{"key":"29002_CR48","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/cdd.2012.107","volume":"20","author":"K Schutters","year":"2013","unstructured":"Schutters, K. et al. Cell surface-expressed phosphatidylserine as therapeutic target to enhance phagocytosis of apoptotic cells. Cell Death Differ. 20, 49\u201356 (2013).","journal-title":"Cell Death Differ."},{"key":"29002_CR49","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/imr.12376","volume":"269","author":"KK Penberthy","year":"2016","unstructured":"Penberthy, K. K. & Ravichandran, K. S. Apoptotic cell recognition receptors and scavenger receptors. Immunol Rev 269, 44\u201359 (2016).","journal-title":"Immunol Rev"},{"key":"29002_CR50","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/35085094","volume":"2","author":"PM Henson","year":"2001","unstructured":"Henson, P. M., Bratton, D. L. & Fadok, V. A. The phosphatidylserine receptor: a crucial molecular switch?. Nat. Rev. Mol. Cell Biol. 2, 627\u2013633 (2001).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"29002_CR51","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1182\/blood.V97.1.288","volume":"97","author":"A Hartnell","year":"2001","unstructured":"Hartnell, A. et al. Characterization of human sialoadhesin, a sialic acid binding receptor expressed by resident and inflammatory macrophage populations. Blood 97, 288\u2013296 (2001).","journal-title":"Blood"},{"key":"29002_CR52","doi-asserted-by":"publisher","unstructured":"Retroviruses use CD169-mediated trans-infection of permissive lymphocytes to establish infection | Science. https:\/\/www.science.org\/doi\/https:\/\/doi.org\/10.1126\/science.aab2749.","DOI":"10.1126\/science.aab2749"},{"key":"29002_CR53","doi-asserted-by":"crossref","unstructured":"Ioannidou, K. et al. In situ characterization of follicular helper CD4 T cells using multiplexed imaging. Front. Immunol. 11, (2021).","DOI":"10.3389\/fimmu.2020.607626"},{"key":"29002_CR54","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/nm.3781","volume":"21","author":"Y Fukazawa","year":"2015","unstructured":"Fukazawa, Y. et al. B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers. Nat. Med. 21, 132\u2013139 (2015).","journal-title":"Nat. Med."},{"key":"29002_CR55","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.cell.2016.06.039","volume":"166","author":"EA Boritz","year":"2016","unstructured":"Boritz, E. A. et al. Multiple origins of virus persistence during natural control of HIV infection. Cell 166, 1004\u20131015 (2016).","journal-title":"Cell"},{"key":"29002_CR56","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/nm.4113","volume":"22","author":"R Banga","year":"2016","unstructured":"Banga, R. et al. PD-1+ and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals. Nat Med 22, 754\u2013761 (2016).","journal-title":"Nat Med"},{"key":"29002_CR57","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1084\/jem.20121932","volume":"210","author":"M Perreau","year":"2013","unstructured":"Perreau, M. et al. Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production. J. Exp. Med. 210, 143 (2013).","journal-title":"J. Exp. Med."},{"key":"29002_CR58","doi-asserted-by":"publisher","unstructured":"Ribeiro, S. P. et al. IL-10 driven memory T cell survival and Tfh differentiation promote HIV persistence. Preprint at https:\/\/doi.org\/10.1101\/2021.02.26.432955 (2021).","DOI":"10.1101\/2021.02.26.432955"},{"key":"29002_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005285","volume":"11","author":"BA Heesters","year":"2015","unstructured":"Heesters, B. A. et al. Follicular dendritic cells retain infectious HIV in cycling endosomes. PLoS Pathog. 11, e1005285 (2015).","journal-title":"PLoS Pathog."},{"key":"29002_CR60","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1128\/JVI.01652-08","volume":"83","author":"TC Thacker","year":"2009","unstructured":"Thacker, T. C. et al. Follicular dendritic cells and human immunodeficiency virus type 1 transcription in CD4+ T cells. J. Virol. 83, 150\u2013158 (2009).","journal-title":"J. Virol."},{"key":"29002_CR61","doi-asserted-by":"publisher","first-page":"e00019","DOI":"10.1128\/AAC.00019-21","volume":"65","author":"EMB Scholz","year":"2021","unstructured":"Scholz, E. M. B. et al. Quantitative imaging analysis of the spatial relationship between antiretrovirals, reverse transcriptase simian-human immunodeficiency virus RNA, and collagen in the mesenteric lymph nodes of nonhuman primates. Antimicrob. Agents Chemother. 65, e00019-21 (2021).","journal-title":"Antimicrob. Agents Chemother."},{"key":"29002_CR62","doi-asserted-by":"publisher","first-page":"eaap8758","DOI":"10.1126\/scitranslmed.aap8758","volume":"11","author":"CG Thompson","year":"2019","unstructured":"Thompson, C. G. et al. Heterogeneous antiretroviral drug distribution and HIV\/SHIV detection in the gut of three species. Sci. Trans. Med. 11, eaap8758 (2019).","journal-title":"Sci. Trans. Med."},{"key":"29002_CR63","doi-asserted-by":"publisher","first-page":"D901","DOI":"10.1093\/nar\/gkm958","volume":"36","author":"DS Wishart","year":"2008","unstructured":"Wishart, D. S. et al. DrugBank: A knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res 36, D901\u2013D906 (2008).","journal-title":"Nucleic Acids Res"},{"key":"29002_CR64","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/S0140-6736(13)61809-7","volume":"382","author":"SG Deeks","year":"2013","unstructured":"Deeks, S. G., Lewin, S. R. & Havlir, D. V. The end of AIDS: HIV infection as a chronic disease. The Lancet 382, 1525\u20131533 (2013).","journal-title":"The Lancet"},{"key":"29002_CR65","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3390\/v11030200","volume":"11","author":"S Zicari","year":"2019","unstructured":"Zicari, S. et al. Immune activation, inflammation, and non-AIDS Co-morbidities in HIV-infected patients under long-term ART. Viruses 11, 200 (2019).","journal-title":"Viruses"},{"key":"29002_CR66","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1146\/annurev-med-042909-093756","volume":"62","author":"SG Deeks","year":"2011","unstructured":"Deeks, S. G. HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med 62, 141\u2013155 (2011).","journal-title":"Annu Rev Med"},{"key":"29002_CR67","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.immuni.2013.10.001","volume":"39","author":"SG Deeks","year":"2013","unstructured":"Deeks, S. G., Tracy, R. & Douek, D. C. Systemic effects of inflammation on health during chronic HIV infection. Immunity 39, 633\u2013645 (2013).","journal-title":"Immunity"},{"key":"29002_CR68","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.idc.2014.05.003","volume":"28","author":"AH Warriner","year":"2014","unstructured":"Warriner, A. H., Burkholder, G. A. & Overton, E. T. HIV-related metabolic comorbidities in the current ART era. Infect. Dis. Clin. North Am. 28, 457\u2013476 (2014).","journal-title":"Infect. Dis. Clin. North Am."},{"key":"29002_CR69","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1128\/AAC.04952-14","volume":"59","author":"CG Thompson","year":"2015","unstructured":"Thompson, C. G. et al. Mass spectrometry imaging reveals heterogeneous Efavirenz distribution within putative HIV reservoirs. Antimicrob. Agents Chemother. 59, 2944\u20132948 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"29002_CR70","doi-asserted-by":"publisher","first-page":"8e758","DOI":"10.1126\/scitranslmed.aap8758","volume":"11","author":"CG Thompson","year":"2019","unstructured":"Thompson, C. G. et al. Heterogeneous antiretroviral drug distribution and HIV\/SHIV detection in the gut of three species. Sci. Transl. Med. 11, 8e758 (2019).","journal-title":"Sci. Transl. Med."},{"key":"29002_CR71","doi-asserted-by":"publisher","first-page":"21169","DOI":"10.1021\/acsomega.9b02582","volume":"4","author":"S Ntshangase","year":"2019","unstructured":"Ntshangase, S. et al. Mass spectrometry imaging demonstrates the regional brain distribution patterns of three first-line antiretroviral drugs. ACS Omega 4, 21169\u201321177 (2019).","journal-title":"ACS Omega"},{"key":"29002_CR72","doi-asserted-by":"publisher","first-page":"11514","DOI":"10.1073\/pnas.95.20.11514","volume":"95","author":"TB Kepler","year":"1998","unstructured":"Kepler, T. B. & Perelson, A. S. Drug concentration heterogeneity facilitates the evolution of drug resistance. Proc. Natl. Acad. Sci. U.S.A. 95, 11514\u201311519 (1998).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"29002_CR73","doi-asserted-by":"publisher","first-page":"E2874","DOI":"10.1073\/pnas.1424184112","volume":"112","author":"S Moreno-Gamez","year":"2015","unstructured":"Moreno-Gamez, S. et al. Imperfect drug penetration leads to spatial monotherapy and rapid evolution of multidrug resistance. Proc. Natl. Acad. Sci. 112, E2874\u2013E2883 (2015).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"29002_CR74","doi-asserted-by":"publisher","first-page":"e69032","DOI":"10.7554\/eLife.69032","volume":"10","author":"AF Feder","year":"2021","unstructured":"Feder, A. F., Harper, K. N., Brumme, C. J. & Pennings, P. S. Understanding patterns of HIV multi-drug resistance through models of temporal and spatial drug heterogeneity. Elife 10, e69032 (2021).","journal-title":"Elife"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29002-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29002-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29002-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T16:02:24Z","timestamp":1777132944000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29002-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["29002"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-29002-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"18 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"45302"}}